OptimizeRx and Reuters Events™ Team Up with I AM ALS and RESOLVE: The National Infertility Association for Innovate4Outcomes™
ROCHESTER, Mich., Nov. 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, in partnership with Reuters Events™ will host its second annual Innovate4Outcomes event, this year focusing on patient access and support challenges. The virtual design thinking event will be held on December 9, 2021 from 1:00-4:30 PM ET.
Achieving higher standards of care and equal access to treatment remains a huge problem for patients in the U.S. Patient advocacy groups like I AM ALS and RESOLVE: The National Infertility Association are critical resources, but still face several barriers when it comes to providing the right support at the right time. Innovate4Outcomes brings together pharma executives, healthcare providers and advocacy leaders to collaborate in finding tangible and actionable solutions, with the goal of driving true patient-centricity across U.S. healthcare.
“Innovate4Outcomes is a true reflection of our mission to help patients start and stay on therapy by connecting key stakeholders along the care journey,” noted Steve Silvestro, chief commercial officer at OptimizeRx. “The turnout and feedback from our first event indicated that there’s an appetite to connect and collaborate across industry groups to discuss potential new solutions to aid in solving systemic healthcare challenges. Having patient advocacy groups of the caliber of I AM ALS and RESOLVE at the table allows participants to hear first-hand the nuances of the patient experience when faced with chronic conditions. We’re excited to have strong patient voices participating in our solutions-building workshop this year. We’re very grateful to count on these organizations and the healthcare leaders joining and supporting this kind of collaboration.”
2021 Innovate4Outcomes virtual event
The 3.5-hour workshop, inspired by technology “hackathons,” brings together 6 groups of 10-15 pharma leaders, healthcare professional representatives, and patients involved with I AM ALS and RESOLVE to collectively “hack” top access and support-related challenges faced by advocacy groups today to create better outcomes for their patient populations.
Teams will pitch their solutions to the other workshop participants and advocacy judges. The winning team will be publicly announced, and their idea may be implemented by I AM ALS or RESOLVE.
Who should attend?
About I AM ALS
About RESOLVE: The National Infertility Association
About Reuters Events
Reuters Events offers help in the sectors where it’s needed most, using specialist industry knowledge to promote development. We research the most difficult business questions to help our customers address their biggest problems and determine their strategy. Whether it’s studies on the progress of emerging technologies, data on fast-moving markets, or updates on regulatory change, we’re always up to speed.
Important Cautions Regarding Forward Looking Statements
Media Relations Contact
Investor Relations Contact
Session Details TBA
Press Room Open for Registered Media, Analysts, Speakers, Exhibitors
Keynote Presentation - Open to all Badge Holders